Mirati Therapeutics to Collaborate with Sanofi on Phase 1/2 Study Evaluating Combination of adagrasib with a SHP2 Inhibitor in KRAS...
Read moreHealthcare Trust of America, Inc. Announces $1.3 Billion Revolving Credit and Term Loan Agreement PR Newswire SCOTTSDALE, Ariz., Oct. 7,...
Read moreStealth BioTherapeutics Presents Positive SBT-272 Preclinical Data at 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting PR Newswire BOSTON, Oct....
Read moreCytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the...
Read moreTrevi Therapeutics Participating in Alliance Global Partners' Virtual Biotech & Specialty Pharma Conference PR Newswire NEW HAVEN, Conn., Oct. 7,...
Read more10x Genomics to Report Third Quarter Financial Results on November 3, 2021 PR Newswire PLEASANTON, Calif., Oct. 7, 2021 PLEASANTON,...
Read moreSanté Canada approuve l'emploi de RINVOQ® (upadacitinib), pour le traitement des adultes et des adolescents atteints de dermatite atopique modérée...
Read moreMeridian Launches New Air-Dryable™ qPCR Mix Enabling Direct Detection of RNA from Whole Blood Samples PR Newswire CINCINNATI, Oct. 7,...
Read moreVuzix and AmbiFi Join Forces to Provide Ambient Technology Solutions for Healthcare Practitioners - Vuzix and AmbiFi will host a...
Read moreHealth Canada Approves the Use of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Moderate to Severe Atopic...
Read more© 2008 - 2022 Expertini World News. All Rights Reserved. Terms - Disclaimer - Cookies - Privacy Policy